46 related articles for article (PubMed ID: 11080809)
1. Alpha interferon restricts human T-lymphotropic virus type 1 and 2 de novo infection through PKR activation.
Cachat A; Chevalier SA; Alais S; Ko NL; Ratner L; Journo C; Dutartre H; Mahieux R
J Virol; 2013 Dec; 87(24):13386-96. PubMed ID: 24089560
[TBL] [Abstract][Full Text] [Related]
2. Genetic evidence of a role for ATM in functional interaction between human T-cell leukemia virus type 1 Tax and p53.
Van PL; Yim KW; Jin DY; Dapolito G; Kurimasa A; Jeang KT
J Virol; 2001 Jan; 75(1):396-407. PubMed ID: 11119608
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of cell proliferation by Tas of foamy viruses through cell cycle arrest or apoptosis underlines the different mechanisms of virus-host interactions.
Jie W; Rui-Fen Z; Zhong-Xiang H; Yan W; Wei-Na L; Yong-Ping M; Jing S; Jing-Yi C; Wan-Hong L; Xiao-Hua H; Zhi L; Yan S
Virulence; 2022 Dec; 13(1):342-354. PubMed ID: 35132916
[TBL] [Abstract][Full Text] [Related]
4. IL-2/IL-2 Receptor Pathway Plays a Crucial Role in the Growth and Malignant Transformation of HTLV-1-Infected T Cells to Develop Adult T-Cell Leukemia.
Maeda M; Tanabe-Shibuya J; Miyazato P; Masutani H; Yasunaga JI; Usami K; Shimizu A; Matsuoka M
Front Microbiol; 2020; 11():356. PubMed ID: 32210945
[TBL] [Abstract][Full Text] [Related]
5. HTLV-1 Extracellular Vesicles Promote Cell-to-Cell Contact.
Pinto DO; DeMarino C; Pleet ML; Cowen M; Branscome H; Al Sharif S; Jones J; Dutartre H; Lepene B; Liotta LA; Mahieux R; Kashanchi F
Front Microbiol; 2019; 10():2147. PubMed ID: 31620104
[TBL] [Abstract][Full Text] [Related]
6. The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.
Forlani G; Abdallah R; Accolla RS; Tosi G
Front Microbiol; 2013; 4():234. PubMed ID: 23986750
[TBL] [Abstract][Full Text] [Related]
7. Tax-1 and Tax-2 similarities and differences: focus on post-translational modifications and NF-κB activation.
Shirinian M; Kfoury Y; Dassouki Z; El-Hajj H; Bazarbachi A
Front Microbiol; 2013; 4():231. PubMed ID: 23966989
[TBL] [Abstract][Full Text] [Related]
8. HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways.
Currer R; Van Duyne R; Jaworski E; Guendel I; Sampey G; Das R; Narayanan A; Kashanchi F
Front Microbiol; 2012; 3():406. PubMed ID: 23226145
[TBL] [Abstract][Full Text] [Related]
9. Ubiquitination and sumoylation of the HTLV-2 Tax-2B protein regulate its NF-κB activity: a comparative study with the HTLV-1 Tax-1 protein.
Turci M; Lodewick J; Di Gennaro G; Rinaldi AS; Marin O; Diani E; Sampaio C; Bex F; Bertazzoni U; Romanelli MG
Retrovirology; 2012 Dec; 9():102. PubMed ID: 23217160
[TBL] [Abstract][Full Text] [Related]
10. Word add-in for ontology recognition: semantic enrichment of scientific literature.
Fink JL; Fernicola P; Chandran R; Parastatidis S; Wade A; Naim O; Quinn GB; Bourne PE
BMC Bioinformatics; 2010 Feb; 11():103. PubMed ID: 20181245
[TBL] [Abstract][Full Text] [Related]
11. Human T-cell leukemia virus I tax protein sensitizes p53-mutant cells to DNA damage.
Mihaylova VT; Green AM; Khurgel M; Semmes OJ; Kupfer GM
Cancer Res; 2008 Jun; 68(12):4843-52. PubMed ID: 18559532
[TBL] [Abstract][Full Text] [Related]
12. HTLV-1 and apoptosis: role in cellular transformation and recent advances in therapeutic approaches.
Taylor JM; Nicot C
Apoptosis; 2008 Jun; 13(6):733-47. PubMed ID: 18421579
[TBL] [Abstract][Full Text] [Related]
13. Persistent inhibition of telomerase reprograms adult T-cell leukemia to p53-dependent senescence.
Datta A; Bellon M; Sinha-Datta U; Bazarbachi A; Lepelletier Y; Canioni D; Waldmann TA; Hermine O; Nicot C
Blood; 2006 Aug; 108(3):1021-9. PubMed ID: 16569765
[TBL] [Abstract][Full Text] [Related]
14. Presence of a functional but dispensable nuclear export signal in the HTLV-2 Tax protein.
Chevalier SA; Meertens L; Calattini S; Gessain A; Kiemer L; Mahieux R
Retrovirology; 2005 Nov; 2():70. PubMed ID: 16285885
[TBL] [Abstract][Full Text] [Related]
15. Animal models for human T-lymphotropic virus type 1 (HTLV-1) infection and transformation.
Lairmore MD; Silverman L; Ratner L
Oncogene; 2005 Sep; 24(39):6005-15. PubMed ID: 16155607
[TBL] [Abstract][Full Text] [Related]
16. HTLV-1 Tax transgenic mice develop spontaneous osteolytic bone metastases prevented by osteoclast inhibition.
Gao L; Deng H; Zhao H; Hirbe A; Harding J; Ratner L; Weilbaecher K
Blood; 2005 Dec; 106(13):4294-302. PubMed ID: 16118323
[TBL] [Abstract][Full Text] [Related]
17. Human T-cell leukemia virus type 1 tax oncoprotein suppression of multilineage hematopoiesis of CD34+ cells in vitro.
Tripp A; Liu Y; Sieburg M; Montalbano J; Wrzesinski S; Feuer G
J Virol; 2003 Nov; 77(22):12152-64. PubMed ID: 14581552
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of p53 by HTLV type 1 and HTLV type 2 Tax trans-activators.
Mahieux R; Pise-Masison CA; Nicot C; Green P; Hall WW; Brady JN
AIDS Res Hum Retroviruses; 2000 Nov; 16(16):1677-81. PubMed ID: 11080809
[TBL] [Abstract][Full Text] [Related]
19. Differences in the ability of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2 tax to inhibit p53 function.
Mahieux R; Pise-Masison CA; Lambert PF; Nicot C; De Marchis L; Gessain A; Green P; Hall W; Brady JN
J Virol; 2000 Aug; 74(15):6866-74. PubMed ID: 10888626
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
